MiniMed Group, Inc. filed a current report on Form 8-K on September 1, 2026, announcing the release of its financial results for the first quarter of fiscal year 2027, ended July 31, 2026.

Key Highlights

  • Filing date: September 1, 2026, with the date of earliest event reported also September 1, 2026.
  • Reporting period: First quarter of fiscal year 2027, ended July 31, 2026.
  • Press release attached: The earnings press release is included as Exhibit 99.1 and incorporated by reference.
  • Slide presentation: An earnings call slide presentation was posted to the Investor Relations section of the company's website at investors.minimed.com.
  • Signed by: Chad Spooner, Executive Vice President and Chief Financial Officer (Principal Financial Officer).

MiniMed Group Announces First Quarter Fiscal 2027 Financial Results

MiniMed Group, Inc. (NASDAQ:MMED), a Delaware corporation headquartered at 18000 Devonshire St., Northridge, CA 91325, filed a Form 8-K with the U.S. Securities and Exchange Commission on September 1, 2026. According to the filing, the company issued a press release on that date disclosing its financial results and related information for the first quarter of fiscal year 2027, which ended July 31, 2026.

The filing covers Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD). The filing noted that the information furnished under these items, including Exhibit 99.1, "shall not be deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, as amended" and "shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing."

The company also disclosed, under Item 7.01, that a slide presentation was being posted in advance of an earnings call to the Investor Relations section of its website at investors.minimed.com. The filing was signed by Chad Spooner, the company's Executive Vice President and Chief Financial Officer, in his capacity as Principal Financial Officer.

What Was Disclosed

MiniMed Group filed an 8-K on September 1, 2026, reporting the issuance of a press release covering its Q1 fiscal 2027 results ended July 31, 2026, with the press release attached as Exhibit 99.1 and a slide presentation posted to its investor relations website.